{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:28:20Z","timestamp":1788413300058,"version":"build-2803163510"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"\n Importance<\/jats:title>\n Most women with multiple sclerosis (MS) will experience menopause while living with MS. Despite this, the impact of menopause on MS disease trajectory remains unclear.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To assess whether menopause modifies the risk of disability progression for women with relapse-onset MS.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This retrospective cohort study used prospective clinical data that were collected within the MSBase Registry. Data were extracted from MSBase on July 1, 2023. These data were analyzed from January 2023 through February 2025. Female participants were recruited from 8 Australian neuroimmunology specialist centers (1 private practice and 7 tertiary referral centers) from 2018 through 2021. Participants included 1468 women aged 18 years or older who completed dedicated retrospective women\u2019s health surveys. Of these, 987 women with relapse-onset MS, 3 or more Expanded Disability Status Scale (EDSS) measurements recorded, and reported menopausal status were included in the primary analysis. The secondary analysis included 209 women with 1 or more EDSS measurements recorded in the MSBase database predate and postdate of menopause onset.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Crude and adjusted Cox proportional hazards models were used to assess the impact of menopause, modeled as a time-varying covariate, on progressive disability milestones. Analyses were adjusted for age at MS onset, baseline disease duration, baseline EDSS score, baseline relapse, and exposure to high-efficacy disease-modifying therapy modeled as a time-varying covariate.<\/jats:p>\n <\/jats:sec>\n \n Main Outcome Measures<\/jats:title>\n In the primary analysis, the main outcome was time to 6-month confirmed disability progression (CDP). The secondary outcome was time to secondary progressive MS (SPMS). The secondary inflection point analysis examined longitudinal changes in EDSS in women who were followed up with throughout their menopausal transition.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Primary analysis included 583 premenopausal and 404 postmenopausal women with MS. The median age at menopause was 48.5 years. Following multivariable adjustment, menopause was not associated with an increased risk of CDP or SPMS (hazard ratio, 0.95; 95% CI, 0.70-1.29;\n P<\/jats:italic>\n \u2009=\u2009.70 and hazard ratio, 1.00; 95% CI, 0.60-1.67;\n P<\/jats:italic>\n \u2009=\u20091.00), respectively. In the secondary analysis, menopause did not represent an inflection point in EDSS worsening following multivariable adjustment.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n While reproductive aging may be additive to the effects of somatic aging, these results do not support menopause as the leading factor for disability progression in older women with MS.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamaneurol.2025.3538","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:30:56Z","timestamp":1759159856000},"page":"1219","source":"Crossref","is-referenced-by-count":12,"title":["Menopause Impact on Multiple Sclerosis Disability Progression"],"prefix":"10.1001","volume":"82","author":[{"given":"Francesca","family":"Bridge","sequence":"first","affiliation":[{"name":"Department of Neuroscience, School of Translational Medicine, Monash University"},{"name":"Department of Neurology, Alfred Health, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"Sanfilippo","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, School of Translational Medicine, Monash University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, School of Translational Medicine, Monash University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Skibina","sequence":"additional","affiliation":[{"name":"Department of Neurology, Alfred Health, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Lan","family":"Nguyen","sequence":"additional","affiliation":[{"name":"CORe, Department of Medicine, University of Melbourne, Australia"},{"name":"Neuroimmunology Centre, Royal Melbourne Hospital, Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Kalincik","sequence":"additional","affiliation":[{"name":"CORe, Department of Medicine, University of Melbourne, Australia"},{"name":"Neuroimmunology Centre, Royal Melbourne Hospital, Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Buzzard","sequence":"additional","affiliation":[{"name":"Neuroimmunology Centre, Royal Melbourne Hospital, Melbourne Australia"},{"name":"Eastern Health Clinical School, Monash University, Box Hill, Victoria, Australia"},{"name":"Department of Neurosciences, Eastern Health, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce V.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia"},{"name":"Department of Neurology, Royal Hobart Hospital, Hobart, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"MacIntyre","sequence":"additional","affiliation":[{"name":"Department of Neurology, Royal Hobart Hospital, Hobart, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley-Ann","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Neurology, Flinders Medical Centre, Adelaide, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Slee","sequence":"additional","affiliation":[{"name":"College of Medicine and Public Health, Flinders University of South Australia, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Macdonell","sequence":"additional","affiliation":[{"name":"Department of Neurology, Austin Health, Heidelberg, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki","family":"Maltby","sequence":"additional","affiliation":[{"name":"Department of Neurology, John Hunter Hospital, Newcastle, Australia"},{"name":"School of Medicine and Public Health, University of Newcastle, Newcastle, Australia"},{"name":"Hunter Medical Research Institute, Newcastle, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette","family":"Lechner-Scott","sequence":"additional","affiliation":[{"name":"Department of Neurology, John Hunter Hospital, Newcastle, Australia"},{"name":"School of Medicine and Public Health, University of Newcastle, Newcastle, Australia"},{"name":"Hunter Medical Research Institute, Newcastle, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"McCombe","sequence":"additional","affiliation":[{"name":"Department of Neurology, Royal Brisbane and Women\u2019s Hospital, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Butzkueven","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, School of Translational Medicine, Monash University"},{"name":"Department of Neurology, Alfred Health, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"van der Walt","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, School of Translational Medicine, Monash University"},{"name":"Department of Neurology, Alfred Health, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilija G.","family":"Jokubaitis","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, School of Translational Medicine, Monash University"},{"name":"Department of Neurology, Alfred Health, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"noi250065r1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1471-2377-13-73","article-title":"No sex-specific difference in disease trajectory in multiple sclerosis patients before and after age 50.","volume":"13","author":"Bove","year":"2013","journal-title":"BMC Neurol"},{"issue":"Pt 6","key":"noi250065r2","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1093\/brain\/aws099","article-title":"The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service.","volume":"135","author":"Wallin","year":"2012","journal-title":"Brain"},{"key":"noi250065r3","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1355817","article-title":"Priority setting: women\u2019s health topics in multiple sclerosis.","volume":"15","author":"Ross","year":"2024","journal-title":"Front Neurol"},{"issue":"8","key":"noi250065r4","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103363","article-title":"The impact of menopause on multiple sclerosis.","volume":"22","author":"Bridge","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"1","key":"noi250065r5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41582-024-01042-x","article-title":"Exploring the role of sex hormones and gender diversity in multiple sclerosis.","volume":"21","author":"Nesbitt","year":"2025","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"noi250065r6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/gme.0b013e31824d8f40","article-title":"Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.","volume":"19","author":"Harlow","year":"2012","journal-title":"Menopause"},{"issue":"1","key":"noi250065r7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/imm.13004","article-title":"Impact of sex hormones on immune function and multiple sclerosis development.","volume":"156","author":"Ysrraelit","year":"2019","journal-title":"Immunology"},{"issue":"4 Pt 1","key":"noi250065r8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/gme.0b013e318174ea4d","article-title":"Cycle and hormone changes during perimenopause: the key role of ovarian function.","volume":"15","author":"Burger","year":"2008","journal-title":"Menopause"},{"issue":"2","key":"noi250065r9","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa185","article-title":"Reproductive history and progressive multiple sclerosis risk in women.","volume":"2","author":"Zeydan","year":"2020","journal-title":"Brain Commun"},{"key":"noi250065r10","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.105517","article-title":"The association of menopausal hormone levels with progression-related biomarkers in multiple sclerosis.","volume":"85","author":"Juutinen","year":"2024","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"noi250065r11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000210228","article-title":"Association of menopause with functional outcomes and disease biomarkers in women with multiple sclerosis.","volume":"104","author":"Silverman","year":"2025","journal-title":"Neurology"},{"issue":"7","key":"noi250065r12","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1177\/1352458515606211","article-title":"Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort.","volume":"22","author":"Bove","year":"2016","journal-title":"Mult Scler"},{"issue":"11","key":"noi250065r13","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1136\/jnnp-2019-320587","article-title":"Impact of natural menopause on multiple sclerosis: a multicentre study.","volume":"90","author":"Baroncini","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"noi250065r14","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/ene.14782","article-title":"Menopause does not modify disability trajectories in a longitudinal cohort of women with clinically isolated syndrome and multiple sclerosis followed from disease onset.","volume":"29","author":"Otero-Romero","year":"2022","journal-title":"Eur J Neurol"},{"issue":"1","key":"noi250065r15","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16566","article-title":"The influence of menopause on multiple sclerosis.","volume":"32","author":"Simonsen","year":"2025","journal-title":"Eur J Neurol"},{"issue":"1","key":"noi250065r16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(22)00184-3","article-title":"Ageing and multiple sclerosis.","volume":"22","author":"Graves","year":"2023","journal-title":"Lancet Neurol"},{"issue":"10","key":"noi250065r17","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1177\/1352458512438236","article-title":"Effect of gender on late-onset multiple sclerosis.","volume":"18","author":"Bove","year":"2012","journal-title":"Mult Scler"},{"issue":"6","key":"noi250065r18","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000208051","article-title":"Clinical characteristics and long-term outcomes of late-onset multiple sclerosis: a Swedish nationwide study.","volume":"102","author":"Mouresan","year":"2024","journal-title":"Neurology"},{"issue":"6","key":"noi250065r19","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1177\/1352458506070775","article-title":"MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis.","volume":"12","author":"Butzkueven","year":"2006","journal-title":"Mult Scler"},{"issue":"3","key":"noi250065r20","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/humupd\/dmac045","article-title":"Anti-M\u00fcllerian hormone for the diagnosis and prediction of menopause: a systematic review.","volume":"29","author":"Nelson","year":"2023","journal-title":"Hum Reprod Update"},{"issue":"8","key":"noi250065r22","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1111\/ene.15406","article-title":"Confirmed disability progression as a marker of permanent disability in multiple sclerosis.","volume":"29","author":"Sharmin","year":"2022","journal-title":"Eur J Neurol"},{"issue":"Pt 9","key":"noi250065r23","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1093\/brain\/aww173","article-title":"Defining secondary progressive multiple sclerosis.","volume":"139","author":"Lorscheider","year":"2016","journal-title":"Brain"},{"issue":"2","key":"noi250065r25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.maturitas.2005.10.003","article-title":"Symptoms of multiple sclerosis in women in relation to sex steroid exposure.","volume":"54","author":"Holmqvist","year":"2006","journal-title":"Maturitas"},{"issue":"3-4","key":"noi250065r26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1159\/000496374","article-title":"The influence of menopause in multiple sclerosis course: a longitudinal cohort study.","volume":"80","author":"Ladeira","year":"2018","journal-title":"Eur Neurol"},{"issue":"5","key":"noi250065r27","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1177\/1971400916666560","article-title":"Structural sex differences at disease onset in multiple sclerosis patients.","volume":"29","author":"Rojas","year":"2016","journal-title":"Neuroradiol J"},{"issue":"10","key":"noi250065r28","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1177\/014107689208501008","article-title":"A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle.","volume":"85","author":"Smith","year":"1992","journal-title":"J R Soc Med"},{"issue":"3","key":"noi250065r29","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1212\/WNL.0000000000004843","article-title":"Ovarian aging is associated with gray matter volume and disability in women with MS.","volume":"90","author":"Graves","year":"2018","journal-title":"Neurology"},{"key":"noi250065r30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.maturitas.2019.10.012","article-title":"Reproductive factors and age at natural menopause: a systematic review and meta-analysis.","volume":"131","author":"Roman Lay","year":"2020","journal-title":"Maturitas"},{"issue":"2","key":"noi250065r31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/oxfordjournals.bmb.a072546","article-title":"Epidemiology of the menopause.","volume":"48","author":"Khaw","year":"1992","journal-title":"Br Med Bull"},{"issue":"10","key":"noi250065r32","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1177\/1352458519853473","article-title":"Obesity worsens central inflammation and disability in multiple sclerosis.","volume":"26","author":"Stampanoni Bassi","year":"2020","journal-title":"Mult Scler"},{"issue":"12","key":"noi250065r33","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.2741\/3543","article-title":"Gender and sex hormones in multiple sclerosis pathology and therapy.","volume":"14","author":"Nicot","year":"2009","journal-title":"Front Biosci (Landmark Ed)"},{"key":"noi250065r34","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.554375","article-title":"Effects of menopause in women with multiple sclerosis: an evidence-based review.","volume":"12","author":"Bove","year":"2021","journal-title":"Front Neurol"},{"key":"noi250065r35","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103747","article-title":"A hormonal therapy for menopausal women with MS: A phase Ib\/IIa randomized controlled trial.","volume":"61","author":"Bove","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"noi250065r21","unstructured":"Roche Diagnostics. Elecsys AMH (anti-m\u00fcllerian hormone). Accessed August 27, 2025. https:\/\/diagnostics.roche.com\/us\/en\/products\/lab\/elecsys-amh-cps-000432.html"},{"key":"noi250065r24","unstructured":"R Core Team. R: A language and environment for statistical computing. Accessed August 27, 2025. https:\/\/www.R-project.org\/"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2839351\/jamaneurology_bridge_2025_oi_250065_1764183383.29826.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T16:01:11Z","timestamp":1765209671000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2839351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2025.3538","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}